Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect
Status:
RECRUITING
Trial end date:
2026-03-25
Target enrollment:
Participant gender:
Summary
The primary purpose of this substudy is to determine if collagen-targeted PET using the type 1 collagen-targeted PET probe, Gallium-68 (68Ga)-labeled collagen binding probe 8 (CBP8) can inform as to drug effect of EGCG and assist in dose selection.
Phase:
PHASE1
Details
Lead Sponsor:
Hal Chapman
Collaborators:
Cornell University Massachusetts General Hospital National Heart, Lung, and Blood Institute (NHLBI) University of Michigan